Analyst Ratings for Sarepta Therapeutics (SRPT)
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $50.00 (BMO Capital)
- Lowest: $5.00 (H.C. Wainwright)
- Average: $23.55
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.55 (+10.4%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$23.55 (+10.4%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
27.00 (N/A) |
19.79 (21.33) |
7.78% | Details |
| 1/28/2026 | Barclays » Updated 3/25/2026 |
Eliana Merle | New Coverage | Equalweight (N/A) |
20.00 (N/A) |
22.80 (21.33) |
-6.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
